SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Company Overview
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap$23.2M
Last DividendNone
Employees2
CEOChristopher Robert Cooper
Valuation
Current Price$4.86
Fair Value?$000.00
Valuation?No valuation
Current PE ?0.16
Hist. PE ?N/Aⓘ
EPS (TTM) ?29.91
Forward EPS Growth ?—
Historical Growth ?58.14%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro
Price?
EPS?
Revenue?
Equity?
ProAvailable on the Pro plan
Free Cash Flow?
ProAvailable on the Pro plan
Long Term Debt?
ProAvailable on the Pro plan
Net Profit?
ProAvailable on the Pro plan
Shares Outstanding?
ProAvailable on the Pro plan
Last updated: 10/23/2026, 11:01:25 PM